5-bromo-2-iodo-3-methylpyridine;5-bromo-3-methylpyridine-2-carbaldehyde;methane
C15H19Br2IN2O — CID 157258711
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-bromo-2-iodo-3-methylpyridine;5-bromo-3-methylpyridine-2-carbaldehyde;methane
5-bromo-2-iodo-3-methylpyridine;5-bromo-3-methylpyridine-2-carbaldehyde;methane (PubChem CID 157258711) has the molecular formula C15H19Br2IN2O and a molecular weight of 530.04 g/mol. Its IUPAC name is 5-bromo-2-iodo-3-methylpyridine;5-bromo-3-methylpyridine-2-carbaldehyde;methane.
Molecular Properties
| Compound Name | 5-bromo-2-iodo-3-methylpyridine;5-bromo-3-methylpyridine-2-carbaldehyde;methane |
|---|---|
| PubChem CID | 157258711 |
| Molecular Formula | C15H19Br2IN2O |
| Molecular Weight | 530.04 g/mol |
| Exact Mass | 527.89 |
| IUPAC Name | 5-bromo-2-iodo-3-methylpyridine;5-bromo-3-methylpyridine-2-carbaldehyde;methane |
| SMILES | C.C.Cc1cc(Br)cnc1C=O.Cc1cc(Br)cnc1I |
| InChI | InChI=1S/C7H6BrNO.C6H5BrIN.2CH4/c1-5-2-6(8)3-9-7(5)4-10;1-4-2-5(7)3-9-6(4)8;;/h2-4H,1H3;2-3H,1H3;2*1H4 |
| InChIKey | AXEVQOIAAISNKO-UHFFFAOYSA-N |
| XLogP | 5.99 |
| TPSA | 42.85 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 530.04 |
| LogP ≤ 5 | 5.99 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157258711 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.